← Eichor
Study identifier: NCT07299097 Synced from ClinicalTrials.gov · July 28, 2026
● Recruiting

Epidemiology of Narcolepsy Type 1 and Type 2 in Spain

Condition: Narcolepsy Type 1 · Narcolepsy Type 2  ·  Sponsor: Takeda

PhaseN/A
Planned participants100
Who can joinAll sexes, 0 Years to no upper limit
Healthy volunteersNo

About this study

The main purpose of this study is to find out how many people in Spain have been diagnosed with narcolepsy type 1 and type 2, and how many new participants are diagnosed each year. Narcolepsy is a rare sleep disorder that causes excessive daytime sleepiness. The researchers will look at medical records from hospitals across Spain to count participants with these conditions and understand patterns in diagnosis over time.

This description comes directly from the study's public registry record.

Talk to the study team

Takeda Contact  ·  +1-877-825-3327  ·  medinfoUS@takeda.com

Always discuss trial participation with your own doctor first.

Locations (10)

Hospital General de CastellónCastellon, Castellon, SpainNot Yet Recruiting
Hospital de NavarraPamplona, Navarre, SpainNot Yet Recruiting
Hospital de la RiberaAlzira, Valencia, SpainNot Yet Recruiting
Hospital Vall d'HebrónBarcelona, SpainNot Yet Recruiting
Hospital Clinic de BarcelonaBarcelona, SpainRecruiting
Hospital Virgen de las NievesGranada, SpainNot Yet Recruiting
Hospital Clínico San CarlosMadrid, SpainActive Not Recruiting
Hospital La PazMadrid, SpainNot Yet Recruiting
Hospital Virgen MacarenaSeville, SpainRecruiting
Hospital de ArabaVitoria-Gasteiz, Álava, SpainNot Yet Recruiting

Follow this study

Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.

We email about this public record only. Unsubscribe anytime with one click. Never medical advice.

Is this your study? This page was generated automatically from the public registry record. Sponsors can claim it — free — to add branding and verified contact routing. Claim this page →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.

Source record: clinicaltrials.gov/study/NCT07299097